These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7107394)

  • 1. The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice.
    McNally NJ; Stephens TC; Twentyman PR; Hinchliffe M; Peacock JH; Spooner D
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):659-62. PubMed ID: 7107394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P; Workman P
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
    McNally NJ
    Br J Cancer; 1982 Oct; 46(4):670-4. PubMed ID: 6291565
    [No Abstract]   [Full Text] [Related]  

  • 4. Misonidazole enhances cyclophosphamide toxicity to bone marrow.
    Allalunis MJ; Turner AR; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):655-8. PubMed ID: 7107393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ; Hinchliffe M; de Ronde J
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitization of mouse tumors by misonidazole.
    Randhawa VS; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):671-4. PubMed ID: 7107397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitization by lipophilic nitroimidazoles.
    Twentyman PR; Workman P
    Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD; Millar JL; McElwain TJ
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
    Stephens TC; Courtenay VD; Mills J; Peacock JH; Rose CM; Spooner D
    Br J Cancer; 1981 Apr; 43(4):451-7. PubMed ID: 7236488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of local hyperthermia on the acute toxicity of misonidazole in mice.
    Overgaard J
    Br J Cancer; 1979 Jan; 39(1):96-8. PubMed ID: 758933
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro pre-incubation with misonidazole under hypoxic conditions--effect on drug response of EMT6 spheroids.
    Twentyman PR
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):607-9. PubMed ID: 7107381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between misonidazole toxicity and core temperature in C3H mice.
    Gomer CJ; Johnson RJ
    Radiat Res; 1979 May; 78(2):329-33. PubMed ID: 451161
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors influencing the chemosensitization of melphalan by misonidazole.
    Randhawa VS; Stewart FA; Denekamp J; Stratford MR
    Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
    Twentyman PR; Workman P
    Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of artificial lung metastases by misonidazole.
    Rockwell S; Nierenburg M; Irvin CG
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG; Brown JM; Hazlehurst JL
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
    Spooner D; Peacock JH; Stephens TC
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):643-6. PubMed ID: 7107390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.